Sergeant First Class Mike Espinoza served three combat deployments to Iraq and Afghanistan. He came home with a Purple Heart, a traumatic brain injury, post-traumatic stress disorder, and a daily prescription for 13 different medications — opioids for pain, benzodiazepines for anxiety, antidepressants for mood, sleep aids for the insomnia that made everything else worse.

When he discovered that cannabis could replace most of those medications — reducing his pharmaceutical regimen to two — the VA had nothing to say. Not because his doctors disapproved, but because federal policy prohibits them from even discussing it as an option.

Espinoza’s story is not unique. It is the story of an estimated 1.3 million veterans who use cannabis to manage service-connected conditions — and the story of a federal healthcare system that refuses to acknowledge what its own patients are telling it.

The Scale of the Problem

Veterans face disproportionately high rates of the conditions for which cannabis shows the most therapeutic promise:

PTSD: An estimated 11-20% of veterans who served in Operations Iraqi Freedom and Enduring Freedom experience PTSD in a given year. For Vietnam veterans, the lifetime prevalence exceeds 30%. The VA treats roughly 500,000 veterans for PTSD annually.

Chronic pain: Over 60% of veterans returning from the Middle East theater report chronic pain, compared to roughly 30% of the general population. Pain is the most common reason veterans seek VA healthcare.

Traumatic brain injury: Over 450,000 TBI diagnoses were recorded among U.S. service members between 2000 and 2023. Mild TBI (concussion) accounts for the majority, but even mild TBI can produce persistent symptoms including headache, sleep disruption, cognitive difficulties, and mood disorders.

Substance use disorder: Veterans are significantly more likely than civilians to be prescribed opioids for pain, and their rate of opioid use disorder is correspondingly elevated. The veteran suicide crisis — over 6,000 veteran suicides per year — is frequently linked to inadequately treated pain, PTSD, and the cascade of pharmaceutical side effects that accompany standard treatment protocols.

These are the exact conditions for which clinical evidence supporting cannabis is strongest.

What the Research Shows

Cannabis for PTSD

PTSD research in veterans has produced some of the most compelling evidence for medical cannabis — building on the broader body of cannabis and PTSD research:

A 2020 study in Journal of Psychoactive Drugs followed 150 medical cannabis patients with PTSD (including a substantial veteran cohort) over one year. The findings: cannabis use was associated with a 75% reduction in PTSD symptom severity as measured by the PTSD Checklist (PCL-5). Over half of participants no longer met diagnostic criteria for PTSD after one year of cannabis treatment.

The Multidisciplinary Association for Psychedelic Studies (MAPS) conducted a triple-blind, randomized, placebo-controlled trial of smoked cannabis in veterans with PTSD. The trial — one of the first federally approved studies of whole-plant cannabis — found that high-THC cannabis produced significant improvements in PTSD symptoms compared to placebo, though the effect did not reach the study’s pre-specified threshold for clinical significance due to a higher-than-expected placebo response.

A 2021 observational study of Canadian veterans prescribed medical cannabis found significant improvements in PTSD symptoms, pain, anxiety, and overall quality of life at 12-month follow-up. The study also found that veterans who used cannabis reduced their use of prescription opioids, benzodiazepines, and antidepressants.

Cannabis for Chronic Pain in Veterans

The VA’s own researchers have acknowledged the potential. A 2017 systematic review by VA researchers published in Annals of Internal Medicine concluded that cannabis is associated with significant reductions in chronic pain and is reasonably well-tolerated. The review was not veteran-specific but formed part of the evidence base that VA clinicians are aware of — even if they cannot act on it.

Multiple veteran-focused surveys have found that cannabis users report significant pain reduction, improved sleep, reduced opioid use, and improved quality of life. A survey of over 9,000 veteran cannabis users by the American Legion found that 92% favored medical cannabis access and 83% wanted the federal government to allow further research.

Cannabis for TBI

Traumatic brain injury research is less advanced but biologically promising. The endocannabinoid system plays a critical role in neuroprotection, neuroinflammation, and neural repair. Animal studies consistently demonstrate that cannabinoids reduce brain swelling, limit secondary injury cascades, and promote neurogenesis after traumatic brain injury.

A retrospective Israeli study found that TBI patients who tested positive for THC at hospital admission had significantly lower mortality rates than THC-negative patients — a finding that, while not proving causation, suggests neuroprotective effects consistent with the preclinical data.

The VA’s Position

The Department of Veterans Affairs occupies an impossible position. As a federal agency, it is bound by federal law, which classifies marijuana as a Schedule I controlled substance with “no currently accepted medical use.” This classification prevents VA physicians from:

  • Recommending cannabis to veterans
  • Prescribing cannabis
  • Completing state medical cannabis certification forms
  • Adjusting other medications based on a veteran’s cannabis use (officially)

What VA physicians can do is limited to: acknowledging that a veteran uses cannabis, recording it in their medical file, and not denying other VA benefits based solely on cannabis use. A 2017 VHA directive clarified that veterans will not lose their VA benefits for using cannabis in compliance with state law.

But the directive explicitly states: “VHA policy does not advocate or encourage the use of marijuana.”

The practical result is that VA clinicians know their patients are using cannabis, often see positive outcomes, but cannot formally integrate cannabis into treatment plans, adjust dosing guidance, monitor for drug interactions, or exercise the kind of clinical oversight that would make cannabis use safer and more effective for veterans.

The Legislative Landscape

Multiple bills addressing veteran cannabis access have been introduced in Congress:

The Veterans Equal Access Act would allow VA physicians to recommend medical cannabis to veterans in states where it is legal. The bill has been introduced in various forms since 2015 and has gained bipartisan support but has not passed.

The Veterans Medical Marijuana Safe Harbor Act would go further, protecting veterans from federal prosecution for cannabis use in compliance with state law and requiring the VA to conduct research on cannabis for service-connected conditions.

The SAFE Veterans Act would specifically require VA research on cannabis for chronic pain and PTSD in veteran populations.

None of these bills have passed both chambers of Congress. The legislative bottleneck is not ideological opposition — polls consistently show over 80% of Americans, including large majorities of Republican voters, support veteran access to medical cannabis. The bottleneck is institutional inertia, competing legislative priorities, and the political complexity of any cannabis reform at the federal level.

What Veterans Are Doing Anyway

In the absence of VA support, veterans have built their own cannabis infrastructure:

Veteran-founded cannabis companies: A disproportionate number of cannabis industry entrepreneurs are veterans. Companies founded by veterans often explicitly serve the veteran community and advocate for policy reform. The discipline, logistics experience, and mission-driven mindset that military service cultivates translate directly to cannabis business operations.

Veteran advocacy organizations: The American Legion, the nation’s largest veterans organization, has formally called for cannabis rescheduling and expanded veteran access. Veterans Cannabis Group, Weed for Warriors, and Operation Grow4Vets provide cannabis access, education, and community for veteran patients.

State-level carve-outs: Several states have established specific provisions for veteran cannabis access, including reduced fees for medical cards, dedicated dispensary hours, and veteran-focused educational programs. Illinois’s Cannabis Regulation and Tax Act includes specific provisions addressing veteran access and social equity.

The Human Cost of Inaction

Every month that the VA is prohibited from recommending cannabis, veterans self-medicate without clinical guidance. They determine their own doses, choose their own products, manage their own drug interactions, and navigate the complex terrain of cannabinoid therapeutics without the medical support system they earned through their service.

Some find effective protocols. Others struggle with products that are too potent, delivery methods that are inappropriate for their condition, or cannabinoid profiles that exacerbate rather than alleviate their symptoms. The lack of clinical oversight does not prevent cannabis use — it just makes cannabis use less safe and less effective than it needs to be.

The question is not whether veterans should use cannabis. Over a million already do. The question is whether the nation’s healthcare system for veterans will acknowledge that reality and provide the clinical support that any other medication would receive.

Until federal policy changes, the answer remains a bureaucratic silence that serves no one — least of all the veterans it claims to protect.